Abstract
Renal cell carcinoma has been linked to hypertension and antihypertensive medications. We investigated the association between renal cell carcinoma and the use of thiazide in a case-control study of 167 men and 90 women. Subjects were members of the Kaiser Permanente Medical Care Program in northern California (United States) who had taken a multiphasic health check-up from 1964 through 1988 and who were evaluated for cancer until the end of 1989. Control subjects received the same check-up, were matched by gender, year of check-up, and age at check-up, and had to be in the health plan until the date on which renal cell carcinoma was diagnosed. Data on known and potential risk factors, including hypertension, body mass index (BMI), and smoking status, were collected from the record of the check-up. Thiazide use was abstracted from the medical chart, which was reviewed from the date of the first entry until the date on which the cancer was diagnosed or the equivalent date for control subjects. The mean follow-back to check-up was 11.3 years. Among women, we found a significantly elevated risk of 4.0 (95 percent confidence interval [CI] 1.5–10.8) associated with ever having used thiazide after we adjusted for smoking, BMI, hypertension, and history of kidney infection at check-up. We did not find a statistically significantly elevated risk in men. Smoking was related to renal cell carcinoma in men (odds ratio [OR] 2.5, CI=1.1–5.4) for those who smoked at least one pack per day compared with those who had never smoked, but was not related in women. We found a statistically nonsignificant relation between BMI and renal cell carcinoma. After we adjusted for thiazide use, we did not find that hypertension was a statistically significant risk factor for renal cell carcinoma. Analysis of the dosage of thiazide measured by time since first use, duration of use, number of mentions of use in the chart, and an estimate of total grams of exposure did not result in any convincing dose-response relation. These findings are consistent with a growing body of data linking antihypertensive medication with renal cell carcinoma. We are unable to conclude whether thiazide use or some other characteristic of hypertensive persons taking these medications is responsible for the association.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma.JNCI 1986;77: 351–6.
McLaughlin JK, Blot WJ, Fraumeni JF Jr. Diuretics and renal cell cancer.JNCI 1988;80: 378.
Asal NR, Lee ET, Geyer JR, Kadamani S, Risser DR, Cherng N, Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions.Cancer Detect Prev 1988;13: 263–79.
Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study.Cancer Causes Control 1993;4: 101–10.
Finkle WD, McLaughlin JK, Rasgon SA, Yeoh HH, Low JE. Increased risk of renal cell cancer among women using diuretics in the United States.Cancer Causes Control 1993;4: 555–8.
Fraser GE, Phillips RL, Beeson WL. Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists.Int J Epidemiol 1990;19: 832–8.
Mellemgaard A, Møller H, OlsenJH. Diuretics may increase risk of renal cell carcinoma.Cancer Causes Control 1992;3: 309–12.
Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study.Am J Epidemiol 1991;134: 942–7.
Lindblad P, McLaughlin JK, Mcllemgaard A, Adami HO. Risk of kidney cancer among patients using analgesics and diuretics: a population-based cohort study.Int J Cancer 1993;55: 5–9.
International Association for Research on Cancer.Pharmaceutical Drugs. Lyon, France: IARC, 1990;IARC Monogr Eval Carcinog Risks Humans, Vol. 50.
Hiatt RA, Friedman GD. The frequency of kidney and urinary tract diseases in a defined population.Kidney Int 1982;22: 63–8.
Kreiger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.Am J Public Health 1992;29: 703–10.
World Health Organization.International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1977.
Buck C, Donner A. Cancer incidence in hypertensives.Cancer 1987;59: 1386–90.
McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF Jr. A population-based case-control study on renal cell carcinoma.JNCI 1984;72: 275–84.
Maclure M, Willett W. A case-control study of diet and risk of renal adenocarcinoma.Epidemiology 1990;1: 430–40.
La Vecchia C, Negri E, D'Avanzo B, Franceschi S. Smoking and renal cell carcinoma.Cancer Res 1990;50: 5231–3.
Goodman MT, Morgenstern H, Wynder EL A case-control study of factors affecting the development of renal cell cancer.Am J Epidemiol 1986;124: 926–41.
Lijinsky W, Reuber MD. Pathologic effects of chronic administration of hydrochlorothiazide, with and without sodium nitrite, to F344 rats.Toxicol Indust Health 1987;3: 413–22.
Holm-Nielsen P, Olsen TS. Ultrastructure of renal adenoma.Ultrastruct Pathol 1988;12: 27–39.
Author information
Authors and Affiliations
Additional information
This study was presented at the Annual Meeting of the Society for Epidemiologic Research, 16–18 June 1993, Keystone, Colorado, USA. The research was supported by US National Cancer Institute grant NCINO1-CP-95606.
Rights and permissions
About this article
Cite this article
Hiatt, R.A., Tolan, K. & Quesenberry, C.P. Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA). Cancer Causes Control 5, 319–325 (1994). https://doi.org/10.1007/BF01804982
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01804982